Preview — Barron's
Tuesday 10/1
The Bureau of Labor Statistics releases the Job Openings and Labor Turnover Survey. The consensus call is for 7.7 million job openings on the last business day of August, slightly more than in July. Job openings are still higher than the prepandemic average but well below the peak of 12.2 million from March 2022. There are currently 1.07 job openings for every unemployed person, the lowest ratio since May 2021.
The Institute for Supply Management releases both its Manufacturing and Services Purchasing Managers' Indexes for September. Consensus estimate for the Manufacturing PMI, which will be released on Tuesday, is for a 47.7 reading, half a point more than in August. Expectations for the Services PMI, to be released on Thursday, is for a 51.5 reading, matching the previous data.
Friday 10/4
The BLS releases the jobs report for September. Economists forecast an increase of 145,000 in nonfarm payrolls, 3,000 more than in August. The unemployment rate is expected to remain unchanged at 4.2%. While the prospects for inflation have brightened, the outlook for the labor market has darkened a bit. Jobs growth has slowed, with an average monthly gain of 116,333 over the past three months, compared with 225,200 in the first five months of this year.
To subscribe to Barron's, visit http://www.barrons.com/subscribe
(END) Dow Jones Newswires
September 27, 2024 21:45 ET (01:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks